Blocking FcRn in humans reduces circulating IgG levels and inhibits IgG immune complex–mediated immune responses

The neonatal crystallizable fragment receptor (FcRn) functions as an intracellular protection receptor for immunoglobulin G (IgG). Recently, several clinical studies have reported the lowering of circulating monomeric IgG levels through FcRn blockade for the potential treatment of autoimmune disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Blumberg, L. J., Humphries, J. E., Jones, S. D., Pearce, L. B., Holgate, R., Hearn, A., Cheung, J., Mahmood, A., Del Tito, B., Graydon, J. S., Stolz, L. E., Bitonti, A., Purohit, S., de Graaf, D., Kacena, K., Andersen, J. T., Christianson, G. J., Roopenian, D. C., Hubbard, J. J., Gandhi, A. K., Lasseter, K., Pyzik, M., Blumberg, R. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920022/
https://www.ncbi.nlm.nih.gov/pubmed/31897428
http://dx.doi.org/10.1126/sciadv.aax9586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920022/
https://www.ncbi.nlm.nih.gov/pubmed/31897428
http://dx.doi.org/10.1126/sciadv.aax9586

Ejemplares similares